General Information of Drug Formulation (ID: F09730)

Formulation Name
Hydrochlorothiazide 50 mg tablet
Company
DAVA Pharmaceuticals; Raritan Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Hydrochlorothiazide DMUSZHD Chronic heart failure BD1Z Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Sunset yellow FCF E00255 17730 Colorant